Rapid Sequencing Technique Accelerates Sepsis Diagnosis HCC
By HospiMedica International staff writers Posted on 16 Mar 2020 |

Image: The MinION handheld nanopore sequencer (Photo courtesy of IGB)
Real-time next-generation sequencing (NGS) allows accurate diagnosis of sepsis-causing agents within a few hours of drawing blood, claims a new study.
Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB; Stuttgart, Germany), Heidelberg University Hospital (Germany), and other institutions developed a diagnostic workflow that uses a handheld nanopore sequencer, the MinION, for real-time high-throughput sequencing of cell-free DNA from plasma, via nanopore sequencing of short fragments with low input amounts. The technique was used to analyze eight samples from four septic patients and three healthy controls, and subsequently validated against standard next-generation sequencing results.
The results revealed that with tailored bioinformatics workflows, all eight septic patient samples were found to be positive for relevant pathogens. When considering the time to diagnosis, the pathogens were identified within minutes; an extrapolation of real-time sequencing performance on a cohort of 239 septic patient samples revealed that with the MinION workflow, more than 90% of pathogen hits would have also been detected. The study was published in the March 2020 issue of The Journal of Molecular Diagnostics.
“With up to 50 million incident sepsis cases and 11 million sepsis-related deaths per year, sepsis represents a major cause of health loss,” said co-lead-investigator Thorsten Brenner, MD, of Heidelberg University Hospital. “Reliable and early identification of the pathogen enables rapid and the most appropriate antibiotic intervention, thereby increasing the chance of better outcomes and patient survival. Currently, standard-of-care diagnostics still rely on microbiological culturing of the respective pathogens, which in most cases do not provide timely positive results.”
The MinION, made by Oxford Nanopore Technologies (United Kingdom) is a pocket-sized device for real-time DNA and RNA sequencing, using up to 512 nanopore channels. Each consumable flow cell generates as much as 30 Gb of DNA sequence data or 7-12 million RNA reads. The MinION streams data into a PC or laptop using a high-speed USB 3.0 cable, or used alongside the MinIT device for real-time, powerful analyses.
Related Links:
Fraunhofer Institute for Interfacial Engineering and Biotechnology
Heidelberg University Hospital
Oxford Nanopore Technologies
Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB; Stuttgart, Germany), Heidelberg University Hospital (Germany), and other institutions developed a diagnostic workflow that uses a handheld nanopore sequencer, the MinION, for real-time high-throughput sequencing of cell-free DNA from plasma, via nanopore sequencing of short fragments with low input amounts. The technique was used to analyze eight samples from four septic patients and three healthy controls, and subsequently validated against standard next-generation sequencing results.
The results revealed that with tailored bioinformatics workflows, all eight septic patient samples were found to be positive for relevant pathogens. When considering the time to diagnosis, the pathogens were identified within minutes; an extrapolation of real-time sequencing performance on a cohort of 239 septic patient samples revealed that with the MinION workflow, more than 90% of pathogen hits would have also been detected. The study was published in the March 2020 issue of The Journal of Molecular Diagnostics.
“With up to 50 million incident sepsis cases and 11 million sepsis-related deaths per year, sepsis represents a major cause of health loss,” said co-lead-investigator Thorsten Brenner, MD, of Heidelberg University Hospital. “Reliable and early identification of the pathogen enables rapid and the most appropriate antibiotic intervention, thereby increasing the chance of better outcomes and patient survival. Currently, standard-of-care diagnostics still rely on microbiological culturing of the respective pathogens, which in most cases do not provide timely positive results.”
The MinION, made by Oxford Nanopore Technologies (United Kingdom) is a pocket-sized device for real-time DNA and RNA sequencing, using up to 512 nanopore channels. Each consumable flow cell generates as much as 30 Gb of DNA sequence data or 7-12 million RNA reads. The MinION streams data into a PC or laptop using a high-speed USB 3.0 cable, or used alongside the MinIT device for real-time, powerful analyses.
Related Links:
Fraunhofer Institute for Interfacial Engineering and Biotechnology
Heidelberg University Hospital
Oxford Nanopore Technologies
Latest Critical Care News
- AI Model Analyzes Patient Data to Diagnose Multiple Sclerosis With 90% Accuracy
- Magnetically Navigable Microparticles Enable Targeted Drug Delivery
- AI-Powered Algorithm Automates Analysis of Coronary Stents After Implantation
- New Stroke Risk Scoring System to Help Avoid Unnecessary Surgeries
- Wearable Device Tracks Individual Cells in Bloodstream in Real Time
- Drug Delivery System Uses Ultrasound-Activated Nanoparticles to Destroy Bacterial Biofilms
- New Potent Injectable Therapy Could Prevent Heart Failure After Heart Attack
- Hospital-Based System Combines AI and Genomic Surveillance to Quickly Detect Infectious Disease Outbreaks
- New Approach to Visualizing Blood Pressure Data Can Help Better Manage Hypertension Patients
- Breakthrough AI Technology Accurately Assesses Heart Failure Severity
- Smart Bandage Monitors Chronic Wounds in Human Patients
- AI Identifies Patients with Increased Lung Cancer Risk Up To 4 Months Earlier
- Next Gen Hemodynamic Monitoring Solution Provides AI-Driven Clinical Decision Support
- AI Algorithm Identifies High-Risk Heart Patients
- Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk
- Wireless, Self-Powered Smart Insole to Improve Personal Health Monitoring
Channels
Surgical Techniques
view channel
DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more